← Leaderboards
Susan R Ross
University Of Pennsylvania
$18,891,931
Attributed
$18,891,931
Total exposure
17
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,281,794 · 18
By mechanism
R01$14,300,026 · 7
P01$4,700,900 · 2
R21$1,739,058 · 4
U54$1,671,843 · 1
R56$479,700 · 1
R03$201,600 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Jaquelin Page Dudley$7,427,251
- Rahul Manu Kohli$12,428,397
- Glen N Gaulton$23,495,239
Others in their field
Top investigators on “Mouse Mammary Tumor Virus”
- Tatyana V. Golovkina · Jackson Laboratory$17,470,940
- Jaquelin Page Dudley · University Of Pennsylvania$6,901,646
- Yi Li · Baylor College Of Medicine$6,420,186
- Piotr Sicinski · Dana-Farber Cancer Inst$6,209,650
- Dihua Yu · University Of Tx Md Anderson Can Ctr$4,752,173
- Julie K Pfeiffer · Ut Southwestern Medical Center$4,752,109
Research focus
Mouse Mammary Tumor VirusInfectionVirusCellsGenesProteinsVirus DiseasesIn VivoViralRetroviridaeMediatingPathway InteractionsAffectKnockout MiceReceptorMurine Leukemia VirusPlayBaseCell TypeResponseCytokineKnock-OutRetroviridae InfectionsTissues
Grant awards (72)
Interplay between reverse transcription and host restriction$518,433
R01 · FY2025 · AI · contact PI
The role of TRIM2 and SIRPA in New World Arenavirus entry$481,188
R01 · FY2025 · AI · contact PI
Interplay between reverse transcription and host restriction$518,433
R01 · FY2024 · AI · contact PI
The role of TRIM2 and SIRPA in New World Arenavirus entry$480,006
R01 · FY2024 · AI · contact PI
Interplay between reverse transcription and host restriction$518,433
R01 · FY2023 · AI · contact PI
The role of TRIM2 and SIRPA in New World Arenavirus entry$493,835
R01 · FY2023 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$479,700
R56 · FY2022 · AI · contact PI
The role of TRIM2 and SIRPA in New World Arenavirus entry$441,075
R01 · FY2022 · AI · contact PI
Role of DDX41 in HSC development and MDS/AML$199,875
R21 · FY2022 · AI · contact PI
Role of DDX41 in HSC development and MDS/AML$239,850
R21 · FY2021 · AI · contact PI
Role of DNA sensors in host anti-retroviral defense$392,454
R01 · FY2020 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$399,750
R01 · FY2019 · AI · contact PI
Role of DNA sensors in host anti-retroviral defense$392,454
R01 · FY2019 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$399,750
R01 · FY2018 · AI · contact PI
Role of DNA sensors in host anti-retroviral defense$392,454
R01 · FY2018 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$399,750
R01 · FY2017 · AI · contact PI
Role of DNA sensors in host anti-retroviral defense$392,454
R01 · FY2017 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$399,500
R01 · FY2016 · AI · contact PI
Role of DNA sensors in host anti-retroviral defense$392,434
R01 · FY2016 · AI · contact PI
APOBEC3-mediated damage of host genomic DNA in vivo$199,813
R21 · FY2016 · AG · contact PI
APOBEC3-mediated damage of host genomic DNA in vivo$240,000
R21 · FY2015 · AG · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$208,016
R01 · FY2015 · AI · contact PI
TRIM2, a novel host factor that restricts New World Arenavirus infection$200,000
R21 · FY2015 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$191,723
R01 · FY2015 · AI · contact PI
Gordon Research Conference on "Infections of the nervous system: Pathogenesis and Worldwide Impact1"$7,000
R13 · FY2015 · NS · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$389,986
R01 · FY2014 · AI · contact PI
TRIM2, a novel host factor that restricts New World Arenavirus infection$240,000
R21 · FY2014 · AI · contact PI
Training in Emerging Infectious Diseases$181,667
T32 · FY2014 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$366,751
R01 · FY2013 · AI · contact PI
Cellular pathways involved in new world arenavirus infections$295,513
U54 · FY2013 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$390,331
R01 · FY2012 · AI · contact PI
Cellular pathways involved in new world arenavirus infections$341,593
U54 · FY2012 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$390,496
R01 · FY2011 · AI · contact PI
Cellular pathways involved in new world arenavirus infections$345,225
U54 · FY2011 · AI · contact PI
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection$393,599
R01 · FY2010 · AI · contact PI
Cellular pathways involved in new world arenavirus infections$351,295
U54 · FY2010 · AI · contact PI
Role of ITAM repeats in virus-induced breast cancer$271,456
R01 · FY2010 · CA · contact PI
Cellular pathways involved in new world arenavirus infections$338,217
U54 · FY2009 · AI · contact PI
Role of ITAM repeats in virus-induced breast cancer$271,456
R01 · FY2009 · CA · contact PI
Role of ITAM repeats in virus-induced breast cancer$88,161
R01 · FY2009 · CA · contact PI
Role of ITAM repeats in virus-induced breast cancer$18,270
R01 · FY2009 · CA · contact PI
Role of ITAM repeats in virus-induced breast cancer$271,456
R01 · FY2008 · CA · contact PI
Role of ITAM repeats in virus-induced breast cancer$271,456
R01 · FY2007 · CA · contact PI
Genetics of Susceptibility to MMTV-Induced Mammary Tumor$328,458
R01 · FY2006 · CA · contact PI
Role of ITAM repeats in virus-induced breast cancer$278,897
R01 · FY2006 · CA · contact PI
Characterization of the MMTV Receptor$270,857
R01 · FY2006 · CA · contact PI
Retroviral interactions with toll-like receptors$193,470
R21 · FY2006 · AI · contact PI
Genetics of Susceptibility to MMTV-Induced Mammary Tumor$336,363
R01 · FY2005 · CA
Characterization of the MMTV Receptor$277,375
R01 · FY2005 · CA
Retroviral interactions with toll-like receptors$226,050
R21 · FY2005 · AI
Role of Cytokines in MMTB Infection$40,320
R03 · FY2005 · TW
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY$918,014
P01 · FY2004 · CA
Genetics of Susceptibility to MMTV-Induced Mammary Tumor$336,363
R01 · FY2004 · CA
Characterization of the MMTV Receptor$277,375
R01 · FY2004 · CA
Role of Cytokines in MMTB Infection$40,320
R03 · FY2004 · TW
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY$891,368
P01 · FY2003 · CA
Genetics of Susceptibility to MMTV-Induced Mammary Tumor$336,363
R01 · FY2003 · CA
Characterization of the MMTV Receptor$277,375
R01 · FY2003 · CA
Role of Cytokines in MMTB Infection$40,320
R03 · FY2003 · TW
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY$865,488
P01 · FY2002 · CA
ROLE OF T AND B CELLS IN MOUSE MAMMARY TUMOR VIRUS INFECTION$103,679
P01 · FY2002 · CA
GENETICS OF SUSCEPTIBILTY TO MMTV INDUCED MAMMARY TUMORS$45,000
R01 · FY2002 · CA
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY$847,523
P01 · FY2001 · CA
GENETICS OF SUSCEPTIBILTY TO MMTV INDUCED MAMMARY TUMORS$299,970
R01 · FY2001 · CA
MMTV RECEPTOR$207,438
R01 · FY2001 · CA
ROLE OF T AND B CELLS IN MOUSE MAMMARY TUMOR VIRUS INFECTION$103,679
P01 · FY2001 · CA
ROLE OF CYTOKINES IN MMTV INFECTION$40,320
R03 · FY2001 · TW
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY$867,470
P01 · FY2000 · CA
GENETICS OF SUSCEPTIBILTY TO MMTV INDUCED MAMMARY TUMORS$291,235
R01 · FY2000 · CA
MMTV RECEPTOR$201,397
R01 · FY2000 · CA
ROLE OF T AND B CELLS IN MOUSE MAMMARY TUMOR VIRUS INFECTION$103,679
P01 · FY2000 · CA
ROLE OF CYTOKINES IN MMTV INFECTION$40,320
R03 · FY2000 · TW